Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Application
1.1.3. End-use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Lithotripsy Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of urolithiasis across the globe
3.4.1.2. Rising demand for extracoroporeal shockwave therapy (ESWT) devices
3.4.1.3. Technological advancements
3.4.2. Market restraint analysis
3.4.2.1. Availability of alternative treatment options
3.4.2.2. Limitations associated with lithotripsy devices
3.5. Lithotripsy Devices Market Analysis Tools
3.5.1. Industry Analysis – Porter’s Five Forces
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Lithotripsy Devices Market: Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Extracorporeal Shock Wave Lithotripsy Devices
4.1.2. Intracorporeal Lithotripsy Devices
4.2. Type Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Lithotripsy Devices Market by Type Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Extracorporeal Shock Wave Lithotripsy Devices
4.5.1.1. Extracorporeal shock wave lithotripsy devices market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Intracorporeal Lithotripsy Devices
4.5.2.1. Intracorporeal lithotripsy devices market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Lithotripsy Devices Market: Application Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Kidney Stones
5.1.2. Ureteral Stones
5.1.3. Pancreatic Stones
5.1.4. Bile Duct Stones
5.2. Application Market Share, 2022 & 2030
5.3. Segment Dashboard
5.4. Lithotripsy Devices Market by Application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Kidney Stones
5.5.1.1. Kidney stones market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Ureteral Stones
5.5.2.1. Ureteral stones market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Pancreatic Stones
5.5.3.1. Pancreatic stones market estimates and forecast 2018 to 2030 (USD Million)
5.5.4. Bile Duct Stones
5.5.4.1. Bile duct stones market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Lithotripsy Devices Market: End-use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals
6.1.2. Ambulatory Surgical Centers
6.1.3. Others
6.2. End-use Market Share, 2022 & 2030
6.3. Segment Dashboard
6.4. Lithotripsy Devices Market by End-use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Hospitals
6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
6.5.2. Ambulatory Surgical Centers
6.5.2.1. Ambulatory surgical centers market estimates and forecast 2018 to 2030 (USD Million)
6.5.3. Others
6.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Lithotripsy Devices Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2022 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2022
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. Market Estimate & Forecasts and Trend Analysis, 2018 to 2030:
7.6. North America
7.6.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.6.2. U.S.
7.6.2.1. Key country dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory framework
7.6.2.4. Reimbursement scenario
7.6.2.5. U.S. market estimates and forecasts, 2018 – 2030
7.6.3. Canada
7.6.3.1. Key country dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory framework
7.6.3.4. Reimbursement scenario
7.6.3.5. Canada market estimates and forecasts, 2018 – 2030
7.7. Europe
7.7.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.7.2. UK
7.7.2.1. Key country dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory framework
7.7.2.4. Reimbursement scenario
7.7.2.5. UK market estimates and forecasts, 2018 – 2030
7.7.3. Germany
7.7.3.1. Key country dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory framework
7.7.3.4. Reimbursement scenario
7.7.3.5. Germany market estimates and forecasts, 2018 – 2030
7.7.4. France
7.7.4.1. Key country dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory framework
7.7.4.4. Reimbursement scenario
7.7.4.5. France market estimates and forecasts, 2018 – 2030
7.7.5. Italy
7.7.5.1. Key country dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Regulatory framework
7.7.5.4. Reimbursement scenario
7.7.5.5. Italy market estimates and forecasts, 2018 – 2030
7.7.6. Spain
7.7.6.1. Key country dynamics
7.7.6.2. Competitive Scenario
7.7.6.3. Regulatory framework
7.7.6.4. Reimbursement scenario
7.7.6.5. Spain market estimates and forecasts, 2018 – 2030
7.7.7. Denmark
7.7.7.1. Key country dynamics
7.7.7.2. Competitive Scenario
7.7.7.3. Regulatory framework
7.7.7.4. Reimbursement scenario
7.7.7.5. Denmark market estimates and forecasts, 2018 – 2030
7.7.8. Sweden
7.7.8.1. Key country dynamics
7.7.8.2. Competitive Scenario
7.7.8.3. Regulatory framework
7.7.8.4. Reimbursement scenario
7.7.8.5. Sweden market estimates and forecasts, 2018 – 2030
7.7.9. Norway
7.7.9.1. Key country dynamics
7.7.9.2. Competitive Scenario
7.7.9.3. Regulatory framework
7.7.9.4. Reimbursement scenario
7.7.9.5. Norway market estimates and forecasts, 2018 – 2030
7.8. Asia Pacific
7.8.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.8.2. Japan
7.8.2.1. Key country dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory framework
7.8.2.4. Reimbursement scenario
7.8.2.5. Japan market estimates and forecasts, 2018 – 2030
7.8.3. India
7.8.3.1. Key country dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory framework
7.8.3.4. Reimbursement scenario
7.8.3.5. India market estimates and forecasts, 2018 – 2030
7.8.4. China
7.8.4.1. Key country dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory framework
7.8.4.4. Reimbursement scenario
7.8.4.5. China market estimates and forecasts, 2018 – 2030
7.8.5. South Korea
7.8.5.1. Key country dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory framework
7.8.5.4. Reimbursement scenario
7.8.5.5. South Korea market estimates and forecasts, 2018 – 2030
7.8.6. Australia
7.8.6.1. Key country dynamics
7.8.6.2. Competitive Scenario
7.8.6.3. Regulatory framework
7.8.6.4. Reimbursement scenario
7.8.6.5. Australia market estimates and forecasts, 2018 – 2030
7.8.7. Thailand
7.8.7.1. Key country dynamics
7.8.7.2. Competitive Scenario
7.8.7.3. Regulatory framework
7.8.7.4. Reimbursement scenario
7.8.7.5. Thailand market estimates and forecasts, 2018 – 2030
7.9. Latin America
7.9.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.9.2. Brazil
7.9.2.1. Key country dynamics
7.9.2.2. Competitive Scenario
7.9.2.3. Regulatory framework
7.9.2.4. Reimbursement scenario
7.9.2.5. Brazil market estimates and forecasts, 2018 – 2030
7.9.3. Mexico
7.9.3.1. Key country dynamics
7.9.3.2. Competitive Scenario
7.9.3.3. Regulatory framework
7.9.3.4. Reimbursement scenario
7.9.3.5. Mexico market estimates and forecasts, 2018 – 2030
7.9.4. Argentina
7.9.4.1. Key country dynamics
7.9.4.2. Competitive Scenario
7.9.4.3. Regulatory framework
7.9.4.4. Reimbursement scenario
7.9.4.5. Argentina market estimates and forecasts, 2018 – 2030
7.10. MEA
7.10.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.10.2. South Africa
7.10.2.1. Key country dynamics
7.10.2.2. Competitive Scenario
7.10.2.3. Regulatory framework
7.10.2.4. Reimbursement scenario
7.10.2.5. South Africa market estimates and forecasts, 2018 – 2030
7.10.3. Saudi Arabia
7.10.3.1. Key country dynamics
7.10.3.2. Competitive Scenario
7.10.3.3. Regulatory framework
7.10.3.4. Reimbursement scenario
7.10.3.5. Saudi Arabia market estimates and forecasts, 2018 – 2030
7.10.4. UAE
7.10.4.1. Key country dynamics
7.10.4.2. Competitive Scenario
7.10.4.3. Regulatory framework
7.10.4.4. Reimbursement scenario
7.10.4.5. UAE market estimates and forecasts, 2018 – 2030
7.10.5. Kuwait
7.10.5.1. Key country dynamics
7.10.5.2. Competitive Scenario
7.10.5.3. Regulatory framework
7.10.5.4. Reimbursement scenario
7.10.5.5. Kuwait market estimates and forecasts, 2018 – 2030
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2022
8.3.4. STORZ Medical AG
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Shenzhen Oceanus Medical Device Co., ltd.
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Medispec
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. BTL
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. MTS Medical
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Shenzhen Huikang Medical Apparatus Co., ltd.
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Dornier MedTech
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Zimmer MedizinSystems GmbH
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Olympus Corporation
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Richard Wolf GmbH
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
8.3.14. Boston Scientific Corporation
8.3.14.1. Company overview
8.3.14.2. Financial performance
8.3.14.3. Product benchmarking
8.3.14.4. Strategic initiatives
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
